| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1357-2725(02)00062-6 |
| P698 | PubMed publication ID | 12379278 |
| P2093 | author name string | Breda Cullen | |
| Jeffrey Hart | |||
| Derek Silcock | |||
| Nicholas D Light | |||
| Paul W Watt | |||
| Stephen Gunnigle | |||
| P2860 | cites work | Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds | Q72429496 |
| TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds | Q72696240 | ||
| Reduction of ultraviolet light-induced oxidative stress by amino acid-based iron chelators | Q73264375 | ||
| Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors | Q73277567 | ||
| Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors | Q73348784 | ||
| Reduced expression of PDGF and PDGF receptors during impaired wound healing | Q73555241 | ||
| Protease inhibitors protect growth factor activity in chronic wounds | Q73924527 | ||
| Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds | Q73969140 | ||
| Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1 | Q74076580 | ||
| Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers | Q74081842 | ||
| Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers | Q77115903 | ||
| Interactions of cytokines, growth factors, and proteases in acute and chronic wounds | Q79798100 | ||
| Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides | Q24561769 | ||
| Collagen-and collagen peptide-induced chemotaxis of human blood monocytes | Q24681328 | ||
| Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate | Q28257965 | ||
| Perspective article: the fate of collagen implants in tissue defects | Q33888957 | ||
| Neutrophil motility in extracellular matrix gels: mesh size and adhesion affect speed of migration | Q33915795 | ||
| Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases | Q33925039 | ||
| Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. | Q34356511 | ||
| Regenerative biology and engineering: strategies for tissue restoration | Q40834753 | ||
| Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors | Q40907637 | ||
| Collagen-based devices for soft tissue repair | Q41058173 | ||
| EGF increases short-term type I collagen accumulation during wound healing in diabetic rats | Q41187468 | ||
| Activation of alveolar macrophages by native and synthetic collagen-like polypeptides | Q41496377 | ||
| Heparan sulphate | Q41557713 | ||
| Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse | Q42492042 | ||
| Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds | Q42930072 | ||
| Prevention of tissue damage: inhibition of myeloperoxidase mediated inactivation of alpha 1-proteinase inhibitor by N-acetyl cysteine, glutathione, and methionine | Q43460099 | ||
| Synovial fluids from infected joints contain active metalloproteinases and no inhibitory activity | Q44405872 | ||
| Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers | Q44884181 | ||
| Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids | Q45100518 | ||
| Interleukin-1alpha and collagenase activity are elevated in chronic wounds | Q45113595 | ||
| MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers | Q45116102 | ||
| Involvement of proteolytic enzymes--plasminogen activators and matrix metalloproteinases--in the pathophysiology of pressure ulcers. | Q52533244 | ||
| The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. | Q52547865 | ||
| Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. | Q52870039 | ||
| PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. | Q54203899 | ||
| Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism | Q57773660 | ||
| Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases | Q63370920 | ||
| Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays | Q67533081 | ||
| In vivo degradation of oxidized, regenerated cellulose | Q68872653 | ||
| Diabetes impairs the late inflammatory response to wound healing | Q70142218 | ||
| Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers | Q70780586 | ||
| Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions | Q70978953 | ||
| Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin | Q71001805 | ||
| Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers | Q71049641 | ||
| Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing | Q71435601 | ||
| Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model | Q71615454 | ||
| Application of Angiogenic Oligosaccharides of Hyaluronan Increases Blood Vessel Numbers in Rat Skin | Q71651138 | ||
| Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes | Q71747000 | ||
| Platelet-derived growth factor levels in wounds of diabetic rats | Q72020422 | ||
| Proteolytic activity in leg ulcer exudate | Q72359058 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1557-1570 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | International Journal of Biochemistry & Cell Biology | Q6051320 |
| P1476 | title | The role of oxidised regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healing | |
| P478 | volume | 34 |
| Q38711539 | Biofunctionalized Plants as Diverse Biomaterials for Human Cell Culture |
| Q92600821 | Biomaterials to Mimic and Heal Connective Tissues |
| Q50913518 | Characterization of alkali-treated collagen gels prepared by different crosslinkers. |
| Q48044077 | Comparative Evaluation of Biological Performance, Biosecurity, and Availability of Cellulose-Based Absorbable Hemostats. |
| Q49686626 | Dual function of active constituents from bark of Ficus racemosa L in wound healing |
| Q33598451 | Effects of different cellulose membranes regenerated from Styela clava tunics on wound healing |
| Q26740156 | Engineered Biopolymeric Scaffolds for Chronic Wound Healing |
| Q84164310 | Experimental study of the tissue reaction caused by the presence of cellulose produced by Acetobacter xylinum in the nasal dorsum of rabbits |
| Q38828182 | Oxidized (non)-regenerated cellulose affects fundamental cellular processes of wound healing |
| Q45990940 | Oxidized Regenerated Cellulose/Collagen Dressings: Review of Evidence and Recommendations. |
| Q36618518 | PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. |
| Q37782101 | Potential applications of natural origin polymer-based systems in soft tissue regeneration |
| Q57163075 | Protease activity as a prognostic factor for wound healing in venous leg ulcers |
| Q24186752 | Protease-modulating matrix treatments for healing venous leg ulcers |
| Q39039023 | Protease-modulating matrix treatments for healing venous leg ulcers. |
| Q26767417 | Topical Collagen-Based Biomaterials for Chronic Wounds: Rationale and Clinical Application |
| Q47297883 | Tracheal inflammatory response to bacterial cellulose dressing after surgical scarification in rabbits |
| Q34620642 | p38 MAPK inhibition reduces diabetes-induced impairment of wound healing |
Search more.